Published online Aug 7, 2021. doi: 10.3748/wjg.v27.i29.4746
Peer-review started: January 28, 2021
First decision: June 14, 2021
Revised: June 23, 2021
Accepted: July 22, 2021
Article in press: July 22, 2021
Published online: August 7, 2021
Processing time: 188 Days and 2.9 Hours
Ischemic bowel disease (ISBODI) includes colon ischemia, acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI). Epidemiologically, colon ischemia is the most common type followed by AMI and CMI. There are various risk factors for the development of ISBODI. Abdominal pain is the common presenting symptom of each type. High clinical suspicion is essential in ordering appropriate tests. Imaging studies and colonoscopy with biopsy are the main diagnostic tests. Treatment varies from conservative measures to surgical resection and revascularization. Involvement of multidisciplinary team is essential in managing ISBODI. Although open surgery with revascularization plays an important role, recently there is an increasing interest in percutaneous endovas
Core Tip: Ischemic bowel disease (ISBODI) includes a spectrum of diseases due to inadequate blood supply to the bowel wall. In this review, we will be discussing the epidemiology, risk factors, pathophysiology, clinical aspects, investigations, current management protocols and prognosis of each type of ISBODI.